share_log

ST目药(600671.SH):可能被实施退市风险警示

ST Eye Droplets (600671.SH): Delisting Risk Warnings May Be Implemented

Gelonghui Finance ·  Apr 19, 2023 16:45

Gelonghui April 19 丨ST Eye Care (600671.SH) announced the “2022 Annual Performance Forecast Correction Notice” (Notice No. 2023-019) disclosed by the company on April 20, 2023. The company's audited net assets at the end of 2022 are expected to be negative. According to the provisions of section 9.3.2 (2) of the “Shanghai Stock Exchange Stock Listing Rules”, “the audited net assets at the end of the most recent fiscal year were negative, or the net assets at the end of the most recent fiscal year after retroactive restatement were negative”, the company's stock trading may be subject to a delisting risk warning by the Shanghai Stock Exchange. Investors are invited to pay attention to investment risks.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment